Peer Review History
| Original SubmissionNovember 27, 2020 |
|---|
|
PONE-D-20-37271 Characterization of genetic diversity and population structure within Staphylococcus chromogenes by multilocus sequence Typing PLOS ONE Dear Dr. Barlow, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses each of the points raised during the review process. Please submit your revised manuscript by Feb 13 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, D. Ashley Robinson, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a well written paper that focuses on the development of a mulilocus typing scheme for Staphylococcus chromogenes. It describes the genetic diversity and population structure of the organism, however, these data are derived from a relative small number of organisms obtained from only three geographic regions and only include a total of 46 sequence types whereas the pubmlst website currently includes 90 sequence types for this organism. If the goal is to study genetic diversity and population structure all of the available sequence types should be included. The usefulness of molecular typing of pathogenic bacteria is in their ability to identify strains associated with disease, virulence factors, host predilection, etc. For completeness the authors should associate each sample with the year of collection, host species, and the disease of their host, if any, with their sequence type. Line 81 and others. The authors state that the seven loci used for their MLST are well separated around its genome. However, (line 135) this is based on a complete genome sequence of a different species, S. hyicus. The whole genome of S. chromogenes is available in GenBank (for example CP046028) and should be used for this purpose. Line 100 Reference 31, presumably cited for identification of S. chromogenes using the tuf gene mentions this species only as being misidentified for another species with the API ID test and does not validate the use of this method for this organism. Validation of this method and a description of any other test used to identify the species of the samples should be included. Table S1. Carbamate kinase is in contig 11 at SCHR_10075 not SCHR_ 09950. Reviewer #2: The authors have developed the first MultiLocus Sequence Typing (MLST) scheme for typing Staphylococcus chromogenes to describe the genetic diversity of this species in relation to pathogenicity. Upon application of the scheme to 120 isolates collected from 3 locations (2 in the US and 1 from Europe, Belgium), the authors show (i) a common lineage including 39 of the 46 sequence types described, (2) a correlation between genotype and geographic location, and (3) a mainly mutational evolution of this dairy cattle mammary pathogen, even if recombination events generated outlier STs. The study is clearly presented and reasonable conclusions are drawn. Therefore, this report is interesting. Here are the questions I feel the authors need to address before publication. Major comments: - Lines 27-28: it is stated that the aim of the study was to develop an MLST scheme in order to “facilitate study of strain variation as a factor of pathogenicity” but I do not see anywhere in the manuscript that pathogenicity was analyzed in relation to the MLST data even though the study included isolates from milk from healthy quarters and from cows with intramammary infections and others from commensal or environmental sources (lines 90-95). - Lines 66-68: In addition to PFGE analyses, the authors should briefly mention that an MLVA scheme was also been developed for S. chromogenes typing (see Ruiz-Romero, DOI: 10.21307/pjm-2018-019) - Lines 159-162: Please comment on these problems in the discussion section. The size of the seven amplicon is particularly large (Table S1). Will the scheme be easily applicable? - The results and discussion section (> Line 187): The results reported here are hardly discussed, if at all compared to the data in the literature. It would be interesting to confront the results of these phylogenetic analyses to that reported for other Staphylococcal species, for which an MLST was developed or for S. agnetis which is a closely related mammary pathogen. Are the evolutionary characteristics reported here highly specific to S. chromogenes? The authors should also describe what MLST brings in relation to the phylogenetic relationships described for S. chromogenes by PFGE and MLVA. The authors must also comment on the two different protocols used to prepare the cell pellets (see lines 108-119). Why did you make a different protocol between the two laboratories? what did it bring? - Lines 87-88: Please give details about the period of collection of the isolates to better describe the geographic distribution of strain types. - Lines 223-227: were the isolates from a single location (eg ST28, ST5) collected over several years? Were isolates with the same ST and from the same geographic place collected from several dairies? Is there a risk of analysing isolates with epidemiological links? Was the profile of antibiotic resistance of the isolates studied? What are the STs of the two pig isolates? - Lines 231-232: how have the percentages of 90.2 and 93 been calculated? - Lines 271-273: were the two ST44 isolates unambiguously identified as S. chromogenes? From what sample were they isolated? Minor comments: Line 195: use directly “SNP” as the abbreviation has already been introduced on line 164 Lines 199 to 200, Line 254-255: gene names (arC, dnaJ, etc.) must be written in italics Line 237: use directly “SLV” as the abbreviation has already been introduced on line 174 Line 242: use directly “DLV” as the abbreviation has already been introduced on line 174 Lines 276-279: The sentence is particularly long. Thus, it is easy to read. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Characterization of genetic diversity and population structure within Staphylococcus chromogenes by multilocus sequence typing PONE-D-20-37271R1 Dear Dr. Barlow, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, D. Ashley Robinson, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-37271R1 Characterization of genetic diversity and population structure within Staphylococcus chromogenes by multilocus sequence typing Dear Dr. Barlow: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. D. Ashley Robinson Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .